Alaunos Therapeutics

TCRT
3.1957.58% ( +0.225 )
交易中: 10月21日 14:42:51 (美東)

全部股東

股東類型

  • 公眾及其他41.37%
  • 對沖基金27.07%
  • 個人與內幕人士25.55%
  • 機構投資者6.01%

主要股東

主要股東 最新
股東
Fairmount Funds Management LLC
27.07%68.78 萬--+68.78 萬13/10/2026
Adrian Price
7.44%18.91 萬0.51%+024/02/2026
Jaime VieserIndependent Director
3.38%8.59 萬1.53%+3.98 萬
Robert PostmaIndependent Director
3.17%8.05 萬0.02%+1,209.0013/10/2026
Watermill Asset Management
2.46%6.24 萬1.12%+2.91 萬13/10/2026
Holger WeisChairman of the Board & CEO
1.93%4.90 萬1.26%+3.25 萬
Michael Jerman
1.76%4.47 萬1.13%+2.91 萬
Vanguard Capital Management, LLC
1.16%2.96 萬0.08%+030/06/2026
BlackRock, Inc.
0.84%2.14 萬0.06%+030/06/2026
Gareth Downing
0.77%1.96 萬0.05%+024/02/2026
Geode Capital Management, LLC
0.76%1.94 萬0.19%-3,204.0030/06/2026
John Nicholls
0.66%1.67 萬0.04%+024/02/2026
Richard Jones
0.63%1.60 萬0.04%+024/02/2026
Chris Cole
0.62%1.59 萬0.04%+024/02/2026
Andrew Turner
0.51%1.30 萬0.04%+024/02/2026
Richard Kotey
0.49%1.25 萬0.03%+024/02/2026
Citadel Advisors LLC
0.47%1.19 萬0.02%+1,351.0030/06/2026
Edward Jones
0.46%1.18 萬0.03%+024/02/2026
Phillip Stead
0.43%1.10 萬0.03%+024/02/2026
Ferdinand GroenewaldVice President of Finance & Corporate Secretary
0.42%1.08 萬0.03%+030/04/2026